Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

23/64 Health Technology Assessment Programme researcher-led (evidence synthesis)

Opens

04 May 2023

Closes

30 August 2023

Contact

  • For help with your application contact htafunding@nihr.ac.uk
  • For more information about the funding Programme, visit the HTA Page
  • Got a research idea and not sure how to turn it into a funding application? The Research Design Service (RDS) supports health and social care researchers across England on all aspects of developing and writing a funding application. Find out how the RDS can help with your application.

Supporting Information

Please note that the Word version of the Stage 1 application form is to be used as a guide and to assist with completion of the online application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

The Health Technology Assessment (HTA) Programme is accepting Stage 1 applications to this funding opportunity.

The HTA Programme aims to commission high-quality, well-designed research which will be carried out by effective and efficient research teams, providing findings which meet the needs of NHS and Social Care managers and leaders.

In order to apply for this call you will need to carefully review the following documents:

Timescales

Any changes to these dates will be emailed to all Lead Applicants with an application in progress.

  • Stage 1 deadline: 1pm, 30 August 2023
  • notification of out of remit/non-competitive decision if unsuccessful: early October 2023
  • notification of Stage 1 shortlisting decision: November 2023
  • Stage 2 writing window: November 2023 to January 2023
  • notification of Stage 2 funding decision: late April/early May 2024
  • start date for funded studies: December/January 2025